Division of Genomic Medicine

The Division of Genomic Medicine promotes the institute's efforts to advance the application of genomics to medical science and clinical care.

Overview

The division plans, directs and facilitates multi-disciplinary research to identify genetic contributions to human health and to advance approaches for the use of genomic data to improve diagnosis, treatment and prevention of disease; through research grants, research training grants, and contracts. The division also:

  • Determines program priorities in genomic medicine and related areas and recommends funding levels.  
  • Assesses needs for research and research training in genomic medicine and related areas.  
  • Prepares reports and analyses to assist Institute staff and advisory groups in carrying out their responsibilities.  
  • Collaborates with the other NHGRI extramural research divisions to establish a balance of resources, personnel, and research and training budgets to achieve NHGRI goals.  
  • Provides expert advice to the director of NHGRI on various aspects of genomic medicine.  
  • Collaborates with the other NHGRI divisions, other National Institutes of Health Institutes and Centers (ICs), and other agencies and entities, national and internationally and maintains an awareness of research efforts in relevant program areas.

Research Programs

Many Division of Genomic Medicine programs have working groups with similar research topics and missions. Division staff has created a matrix of research topics across programs to promote the sharing of ideas between these working groups.

Meetings and Workshops

  • Genomic Medicine XII
    On May 6-7, 2019, the National Human Genome Research Institute (NHGRI) will sponsor its 12th Genomic Medicine meeting, Genomic Medicine XII: Genomics and Risk Prediction. The objectives of the meeting are: Review the state of science of polygenic risk scores and how it can be improved; Examine other information sources that should be integrated with genetic variant information in predicting risk; and Identify research directions in development and implementation of genomic risk prediction.
     
  • Genomic Medicine XI
    On September 5-6, 2018, the National Human Genome Research Institute (NHGRI) sponsored its 11th Genomic Medicine meeting - Genomic Medicine XI: Research Directions in Genomic Medicine Implementation - at the Hilton La Jolla Torrey Pines hotel in La Jolla, California. The objectives of the meeting were to: summarize the current status of genomic medicine implementation research; identify obstacles to genomic medicine implementation and how to overcome them; define where clinical implementation of genomic medicine could or should be 5-10 years from now and how to get there; and inform NHGRI strategic planning process regarding genomic medicine.
     
  • Revisiting the Missing Heritability of Complex Diseases, Ten Years On
    On May 1-2, 2018, the National Human Genome Research Institute (NHGRI), sponsored the NHGRI Workshop, Missing Heritability Ten Years On,  in Silver Spring, Maryland. The workshop's objectives were to review scientific progress in the area of missing heritability and answer: (1) What have we learned since 2008? (2) What has been and/or will be the value of identifying the sources of missing heritability? (3) What research can and/or should be pursued to determine these sources?
     
  • Genomic Medicine for Reproductive, Prenatal and Neonatal Health
    On April 16-17, 2018, the National Human Genome Research Institute (NHGRI) and the Eunice Kennedy Shriver National Institute of CHild Health and Human Development (NICHD) hosted a joint workshop - Genomic Medicine for Reproductive, Prenatal and Neonatal Health - at 6710B Rockledge Drive in Bethesda, Maryland. The workshop addressed the following questions: (1) What current genomic technologies are ready for implementation in reproductive, prenatal and neonatal health? (2) What are the ethical, legal and social implications of genomic medicine implementation in reproductive, prenatal and neonatal health? (3) What are the challenges to implementing genomic medicine in reproductive, prenatal and neonatal health?
     
  • Genomic Medicine X
    On May 2-3, 2017, the National Human Genome Research Institute (NHGRI), sponsored its tenth Genomic Medicine meeting - Research Directions in Pharmacogenomics Implementation - at the Sheraton Silver Spring Hotel in Silver Spring, Maryland. The meeting convened leaders in genomic medicine and pharmacogenomics (PGx) to survey the landscape of PGx implementation and assess projects that are ripe for clinical use. Although variant and drug-gene interaction discovery is essential for generating the evidence to move implementation forward, the purpose of this meeting is to identify and address the gaps and limitations that have hindered the implementation of PGx and its incorporation into clinical care.
     
  • eMERGE & Beyond: The Convergence of Genomics and Medicine
    On February 2, 2017, the National Human Genome Research Institute (NHGRI) will webcast the meeting eMERGE & CSER: The Convergence of Genomics and Medicine at the Bethesda Hyatt in Bethesda, Maryland. The meeting will focus on research that seeks to rapidly advance the knowledge necessary to develop best practices for the implementation of genomic sequence data into clinical care, as well as research that combines biorepositories with electronic medical record (EMR) systems for genomic discovery and genomic medicine implementation research.
     
  • IGNITE and Beyond: The Future of Genomic Medicine Implementaiton
    On August 30, 2016, the National Human Genome Research Institute (NHGRI), sponsored the IGNITE and Beyond: The Future of Genomic Medicine Implementation meeting to discuss future opportunities surrounding the integration of genomic medicine into routine clinical care. The meeting objectives were to: 1. evaluate the key contributions of IGNITE to genomic medicine implementation; 2. identify and prioritize the set of scientific opportunities that could fill gaps in the field of genomic medicine implementation; and 3. identify optimal topics for future genomic medicine implementation research.
     
  • NHGRI International Genomics Education Meeting
    On August 4-5, 2016, the National Human Genome Research Institute (NHGRI), sponsored the NHGRI International Genomics Education Meeting at the Lawton Chiles International House in Bethesda, Md. The meeting brought together genomics education leaders and innovators to review primary care oriented education programs, share best practices for genomic education implementation, and identify synergies, challenges, and opportunities to share and collaborate.
     
  • Genomic Medicine IX
    On April 19-20, 2016, the National Human Genome Research Institute (NHGRI), sponsored its ninth Genomic Medicine meeting - Bedside to Bench - Mind the Gaps - at the Sheraton Silver Spring Hotel in Silver Spring, Maryland. The meeting focused on facilitating bedside back to bench research by focusing on one of the most vexing problems in clinical sequencing: characterizing and interpreting variants of uncertain significance (VUS).
     
  • Genomic Medicine VIII
    On June 8-9, 2015, the National Human Genome Research Institute (NHGRI), sponsored its eighth Genomic Medicine meeting - NHGRI's Genomic Medicine Portfolio - at the at the Hilton Washington D.C./Rockville Hotel & Executive Meeting Center in Rockville, Md. The meeting convened leadership from NHGRI's genomic medicine programs and representatives from other NIH Institutes and Centers (ICs) and external groups to review NHGRI's ongoing genomic medicine portfolio and identify gaps and opportunities for collaborations among these programs.
     
  • Research Directions in Genetically-Mediated Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis
    On March 3-4, 2015, the National Institutes of Health (NIH) and the Food and Drug Administration (FDA) sponsored a workshop - Research Directions in Genetically-Mediated Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis - at Building 31 on NIH Main Campus. The objectives of the workshop are to: review current state of knowledge of surveillance, pathogenesis, and treatment of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis (SJS/TEN), examine role of genomics and pharmacogenomics in etiology, treatment, and eradication of preventable causes of drug-induced SJS/TEN amd identify gaps, unmet needs, and priorities for future research to eliminate genetically mediated SJS/TEN globally.
     
  • Genomic Medicine VII
    On October 2-3, 2014, the National Human Genome Research Institute (NHGRI), sponsored its seventh Genomic Medicine meeting - Genomic Clinical Decision Support: Developing Solutions for Clinical and Research Implementation - at the Bethesda North Marriott Hotel & Conference Center in North Bethesda, Md. Blackford Middleton, M.D., M.P.H., M.Sc., Vanderbilt University, and Marc Williams, M.D., Geisinger Health System, co-chaired the meeting. The meeting convened key thought leaders in genomic medicine implementation and application of clinical decision support.
     
  • Genomic Medicine VI
    On January 8-9, 2014, the National Human Genome Research Institute (NHGRI), sponsored its sixth Genomic Medicine Centers meeting - Genomic Medicine Centers Meeting VI: Global Leaders in Genomic Medicine - at the National Academy of Sciences Building in Washington, D.C. Geoffrey Ginsburg, M.D., Ph.D., Duke University, and Teri Manolio, M.D., Ph.D., NHGRI, co-chaired the meeting. The goals of the meeting were to: identify areas of active translational and implementation research, potential common strategies, and opportunities for collaborative efforts; identify common barriers to implementation of genomics in healthcare and a policy agenda relevant to advances in the field; identify nations with unique capabilities (such as national healthcare systems) that may allow rapid implementation and measures of key outcomes; and discuss opportunities (such as national healthcare system) that may allow rapid implementation and measures of key outcomes.
     
  • Genomic Medicine V
    On May 28-29, 2013, the National Human Genome Research Institute (NHGRI), sponsored its fifth Genomic Medicine Centers meeting - Genomic Medicine Centers Meeting V: Working with Federal Stakeholders - at the Hyatt Regency Bethesda in Bethesda, Md. Rex Chisholm, Ph.D., Northwestern University and Teri Manolio, M.D., Ph.D., NHGRI co-chaired the meeting. The goals of the meeting were to: review ongoing and planned activities and obstacles to the implementation of genomic medicine by U.S. federal agencies; understand how NHGRI and NIH can facilitate or expand work by U.S. federal agencies; Establish needs and goals in the implementation of genomic medicine in anticipation of discussions with international stakeholders at Genomic Medicine VI; and learn about ongoing genomic medicine initiatives at centers nationwide and within NIH.
     
  • Genomic Medicine IV
    On January 28-29, 2013, the National Human Genome Research Institute (NHGRI), sponsored its fourth Genomic Medicine Centers meeting - Genomic Medicine Centers Meeting IV: Physician Education in Genomics - at the Hyatt Regency DFW in Dallas, Texas. Teri Manolio, M.D., Ph.D., NHGRI and Marc Williams, M.D., Geisinger Health System, co-chaired the meeting. The goals of the meeting were to: identify ongoing efforts and current needs in physician education in genomics; understand processes for guideline development in the use of genomics; promote collaborations among the societies; and learn about ongoing genomic medicine initiatives at centers nationwide and within NIH.
     
  • Implicating Sequence Variants in Human Disease
    On September 12-13, 2012, the National Human Genome Research Institute (NHGRI), sponsored a workshop - Implicating Sequence Variants in Human Disease - at the Hyatt Regency Bethesda, in Bethesda, Md. Teri Manolio, M.D., Ph.D., NHGRI, and Daniel MacArthur, Ph.D., Massachusetts General Hospital, co-chaired the workshop. The goal of the workshop was to develop guidelines for investigators, reviewers and editors to consider in assessing the evidence implicating sequence variants or genes as causal in a specific disease.
     
  • Sequencing in Cohort Studies and Large Sample Collections
    On June 28-29, 2012, the National Human Genome Research Institute (NHGRI), sponsored a trans-NIH workshop - Sequencing in Cohort Studies and Large Sample Collections - in Wilson Hall, Building 1, at the National Institutes of Health in Bethesda, Md. Teri Manolio, M.D., Ph.D., NHGRI, and Eric Boerwinkle, Ph.D., University of Texas Health Science Center, co-chaired the workshop. The workshop had the following goals/objectives: provide guidance to NIH and the scientific community on the utility of sequencing large sample collections to improve the understanding and treatment of complex diseases; identify the key scientific questions that can be addressed by sequencing and define criteria for selecting samples to answer those questions.
     
  • Genomic Medicine III
    On May 3-4, 2012, the National Human Genome Research Institute (NHGRI), sponsored its third Genomic Medicine Centers meeting - Genomic Medicine Centers Meeting III: Working with Implementation Stakeholders - at the International Ballroom-Hilton Chicago O'Hare Airport, Chicago, Ill. The workshop had the following goals: review early-stage deliverables from each of the pilot project working groups established at the December 2011 meeting; identify barriers and possible solutions to genomic medicine implementation with payers and other stakeholders; and develop approaches for collaborations among genomic medicine centers.
     
  • Genomic Medicine II
    On Dec. 5-6, 2011, the National Human Genome Research Institute (NHGRI), sponsored its second Genomic Medicine Centers meeting - Genomic Medicine Centers Meeting II - at the Hyatt Regency Bethesda, Md. Rex Chisholm, Ph. D., Northwestern University, and Teri Manolio, M.D., Ph.D., NHGRI, co-chaired the meeting gathered genomics researchers, experts and professionals.
     
  • Characterizing and Displaying Genetic Variants for Clinical Action Workshop
    On Dec. 1-2, 2011, the National Human Genome Research Institute (NHGRI), organized a workshop - Characterizing and Displaying Genetic Variants for Clinical Action Workshop - at the Marriott Washingtonian Center I Gaithersburg, Md. The goal of the workshop was to consider the processes and resources needed to identify clinically relevant genetic variants; to decide whether they are actionable and what the action should be; and to provide this information for clinical use.
     
  • Genomic Medicine Symposium
    On June 29, 2011, the National Human Genome Research Institute (NHGRI) sponsored its first Genomic Medicine Colloquium meeting at the Marriott O'Hare in Chicago. NHGRI hosted this meeting in conjunction with the Disease-Oriented Genomic Medicine group to discuss ongoing genomic medicine projects nationwide, assess obstacles and barriers to implementing genomic medicine projects, and develop a research strategy for NHGRI and NIH to accelerate clinical implementation of future projects.
     
  • Gene-Environment Interplay in Common Complex Diseases: Forging an Integrative Model 
    Held January 25, 2010 in Bethesda, Md. at Natcher Auditorium, NIH campus. The goal of the workshop was to engage the scientific community in discussing and conceptualizing a truly trans-disciplinary model of gene-environment research that fully integrates the "genetics" and "environment" sides of the gene-environment equation. The workshop featured presentations to showcase the state-of-the-science and focused discussions to articulate future needs and directions in research and training on gene-environment interplay related to health. This workshop was sponsored by the National Institutes of Health (NIH) Office of Behavioral and Social Sciences Research (OBSSR) in conjunction with the NIH Genes, Environment and Health Initiative.
     
  • New Models for Large Prospective Studies Symposium
    Held January 22, 2010 in Bethesda, Md. at Natcher Auditorium, NIH campus. The main objective of the symposium was to discuss novel approaches to designing and implementing large prospective cohort studies and biobanks to examine genetic, lifestyle, and environmental factors that contribute to human disease. This symposium featured the UK Biobank. NIH hosted this symposium to hear first-hand from the leadership of the UK Biobank, as well as from other large national and international endeavors, about novel designs for large prospective cohorts that may inform future NIH efforts.
     
  • The Dark Matter of Genomic Associations with Complex Diseases: Explaining the Unexplained Heritability from Genome-Wide Association Studies
    Held February 2-3, 2009 in Bethesda, Md. The Dark Matter of Genomic Associations with Complex Diseases: Finding the Unexplained Heritability from Genome-Wide Association Studies workshop was convened to examine the potential sources of missing heritability and propose research strategies, including and extending beyond current genome-wide association study approaches, in order to illuminate the genetics of complex diseases.
     
  • Epidemiology for Researchers Performing Genetic/Genomic Studies
    Held July 18, 2008 in Bethesda, Md. at Natcher Auditorium, NIH campus, this short course was for investigators and trainees doing research in human genetics, particularly studies employing genomic analyses of samples from human populations. It consisted of eight lectures aimed at familiarizing researchers studying the human genome with basic principles and potential pitfalls of epidemiology as applied to human genome research.
     
  • Genetics for Epidemiologists: Application of Human Genomics to Population Sciences
    Held May 13-14, 2008 at Northwestern University in Chicago, Genetics for Epidemiologists: Application of Human Genomics to Population Sciences, was a short course for investigators and trainees in the field of epidemiology and related population-based sciences. The course consisted of eight one-hour lectures and focused on the interface between genetics and epidemiology.
     
  • Frontiers in Population Genomics Research Meeting
    Held December 18-19, 2007 in Bethesda, Md., the Frontiers workshop was held to chart future research directions for NHGRI to pursue in population genomics, defined as the application of genomic technologies to population studies, to meet the goals of NHGRI and NIH in improving health and reducing disease.
     
  • Designing Geneticists: Study Design Issues in Population-Based Genetics and Genomics Research
    The 2007 American Society of Human Genetics meeting was held in San Diego, October 23-27. Presentation slides regarding study design and minimizing bias in population-based genetic studies are now available for download.
     
  • Genome-Wide Association Studies for the Rest of Us: Adding Genome-Wide Association to Population Studies
    The National Institutes of Health co-sponsored a seminar on Genome-Wide Association Studies at the June 22, 2007 meeting of the Society for Epidemiological Research in Boston. Lecture and discussion videos and presentation slides from the seminar are available for download.
     
  • Multi-IC Symposia on the Application of Genomic Technologies to Population-Based Studies: Facilitating Collaboration in Genome-Wide Association Studies
    Two NIH-wide symposia held in 2006 and 2007 in order to increase the level of familiarity and understanding of GWA studies within NIH, and to develop collaborations within or across ICs for carrying out these studies.

 

 

Funding Opportunities

  • NOT-HG-19-020 Notice Announcing the National Human Genome Research Institute's Genomics in Medicine and Health Strategic Planning Workshop
    Release Date: April 17, 2019
  • NOT-HG-19-019 Notice of Availability of Administrative Supplements for Short-term Research Career Enhancement in Genomics for Experienced Investigators
    Release Date: March 28, 2019

  • NOT-HG-19-018 Notice of Change in the Number of Trainee Slots on NHGRI T32 Postdoctoral Training Program in Genomic Medicine Research
    Release Date: March 5, 2019

  • NOT-HG-19-017 Ruth L. Kirschstein National Research Service Award Fellowship for Students at Institutions without NIH-Funded Institutional Predoctoral Dual-Degree Training Programs (Parent F30)
    Release Date: March 5, 2019

  • NOT-HG-19-016 Ruth L. Kirschstein National Research Service Award Fellowship for Students at Institutions with NIH-Funded Institutional Predoctoral Dual-Degree Training Programs (Parent F30)
    Release Date: March 4, 2019

  • PA-19-188 Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (Parent F32)
    Posted Date: Feb 22, 2019

  • PA-19-195 Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship (Parent F31)
    Posted Date: Feb 22, 2019

  • PA-19-196 Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship to Promote Diversity in Health-Related Research (Parent F31)
    Posted Date: Feb 22, 2019
  • PAR-19-185 Initiative to Maximize Research Education in Genomics: Courses (R25 Clinical Trial Not Allowed)
    Due Date: May 25, 2019

  • NOT-HG-19-010 Notice to Encourage Eligible NHGRI Awardees to Apply for PA-18-906 "Research Supplements to Promote Diversity in Health-Related Research"
    Release Date: December 19, 2018

  • PA-18-372 Mentored Clinical Scientist Research Career Development Award (Parent K08 - Independent Clinical Trial Required)
    Open Date: January 12, 2018

  • PA-18-373 Mentored Clinical Scientist Research Career Development Award (Parent K08 - Independent Clinical Trial Not Allowed)
    Open Date: January 12, 2018

  • PA-18-867 Novel Approaches for Relating Genetic Variation to Function and Disease (R21 Clinical Trial Not Allowed)
    Open Date (Earliest Submission Date): September 16, 2018
    Expiration Date: July 17, 2021
     
  • PA-18-868 Novel Approaches for Relating Genetic Variation to Function and Disease (R01 Clinical Trial Not Allowed)
    Open Date (Earliest Submission Date): September 5, 2018
    Expiration Date: July 6, 2021
  • RFA-HG-18-006 Genomic Innovator Award (R35 Clinical Trial Optional)
    Application Due Date(s): September 30, 2018; October 30, 2018; October 30, 2019; October 30, 2020
    Expiration Date: October 31, 2020

  • PAR-18-735 Investigator-Initiated Genomic Medicine Research (R01 Clinical Trial Optional)
    Application Due Date(s): June 20, 2018; October 19, 2018; June 20, 2019; October 21, 2019; June 19, 2020; October 20, 2020
    Expiration Date: January 23, 2021

  • PAR-18-736 Investigator-Initiated Genomic Medicine Research (R21 Clinical Trial Optional)
    Application Due Date(s): June 20, 2018; October 19, 2018; June 20, 2019; October 21, 2019; June 19, 2020; October 20, 2020
    Expiration Date: January 23, 2021

  • NOT-HG-15-014 Notice of Pre-Application Webinar for PA-14-015 "Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grants (Parent T32)" Related to the Creation of New NHGRI Postdoctoral Training Programs in Genomic Medicine Research
    Release Date: February 5, 2015

Expired Funding Opportunities

2017

  • RFA-RM-17-015 Metabolomics Core for the Undiagnosed Diseases Network (UDN) Phase II (U01)
    Release Date: August 15, 2017

  • RFA-RM-17-016 Sequencing Core(s) for the Undiagnosed Diseases Network (UDN) Phase II (U01)
    Release Date: August 15, 2017
  • RFA-RM-17-017 Model Organisms Screening Center for the Undiagnosed Diseases Network (UDN) Phase II (U54)
    Release Date: August 15, 2017

  • RFA-RM-17-018 Coordinating Center for the Undiagnosed Diseases Network (UDN) Phase II (U01)
     
  • RFA-RM-17-019 Clinical Sites for the Undiagnosed Diseases Network (UDN) Phase II (U01)
    Release Date: August 15, 2017
     
  • RFA-HG-17-011 The NHGRI Genomic Data Science Analysis, Visualization, and Informatics Lab-space (AnVIL) (U24)
    Application Due Date(s): November 9, 2017
    Expiration Date: November 10, 2017
  • NOT-HG-17-014 Notice of Applicant Information Webinar and Frequently Asked Questions (FAQ) for NHGRI IGNITE II RFAs: RFA-HG-17-008, RFA-HG-17-009 and RFA-HG-17-010
     
  • RFA-HG-17-008 Implementing Genomics in Practice (IGNITE) II: Pragmatic Clinical Trials - Clinical Groups (U01) 
    Application Due Date(s): November 3, 2017
    Expiration Date: November 4, 2017

     
  • RFA-HG-17-009 Implementing Genomics in Practice (IGNITE) II: Pragmatic Clinical Trials -Enhanced Diversity Clinical Groups (U01)
    Application Due Date(s): November 3, 2017
    Expiration Date: November 4, 2017

     
  • RFA-HG-17-010 Implementing Genomics in Practice (IGNITE) II: Pragmatic Clinical Trials -Coordinating Center (U01)
    Application Due Date(s): November 3, 2017
    Expiration Date: November 4, 2017

2016

  • RFA-HG-16-010 Clinical Sequencing Evidence-Generating Research (CSER2) - Clinical Sites (U01)

    • NOT-HG-16-021 Notice Announcing Pre-application Information Webinar for Clinical Sequencing Evidence-generating Research (CSER2) Requests For Applications (RFAs) and Frequently Asked Questions (FAQ) regarding Clinical Sequencing Funding Opportunities
      Release Date: May 6, 2016
       
  • RFA-HG-16-011 Clinical Sequencing Evidence-Generating Research (CSER2) - Clinical Sites with Enhanced Diversity (U01)
    Release Date: May 6, 2016
     
  • RFA-HG-16-012 Clinical Sequencing Evidence-Generating Research (CSER2) - Coordinating Center (U24)
    Release Date: May 6, 2016
     
  • PAR-16-209 Investigator-Initiated Clinical Sequencing Research (R01) 
    Release Date: April 19, 2016
  • PAR-16-274 Serious Adverse Drug Reaction Research (R21) 
    Release Date: May 19, 2016

  • PAR-16-275 Serious Adverse Drug Reaction Research (R01) 
    Release Date: May 19, 2016

  • PAR-16-435 Genomics of HIV/AIDS Drug Response and Co-Morbidities (R01) 
    Release Date: September 16, 2016

2015

  • NOT-HG-15-014 Notice of Pre-Application Webinar for PA-14-015 "Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grants (Parent T32)" Related to the Creation of New NHGRI Postdoctoral Training Programs in Genomic Medicine Research
    Release Date: February 5, 2015

2014

  • NOT-HG-14-017 Notice of NHGRI Participation in PA-14-015 "Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grants (Parent T32)" and Creation of New NHGRI Postdoctoral Training Programs in Genomic Medicine Research 
    Release Date: January 10, 2014
     
  • RFA-HG-14-025 The Electronic Medical Records and Genomics (eMERGE) Network, Phase III - Study Investigators (U01)
    Release Date: July 9, 2014
     
  • RFA-HG-14-026 The Electronic Medical Records and Genomics (eMERGE) Network, Phase III - Coordinating Center (U01)
    Release Date: July 17, 2014
     
  • RFA-HG-14-027 The Electronic Medical Records and Genomics (eMERGE) Network, Phase III - Central Genome Sequencing and Genotyping Facility (U01)
    Release Date: July 17, 2014
     

2013

  • RFA-HD-13-010 Genomic Sequencing and Newborn Screening Disorders (U19)
    Release Date: August 9, 2012

2012

2011

  • NOT-HG-11-021 Notice of the National Human Genome Research Institute's Interest in Receiving Applications to Analyze and Develop Methods for X Chromosome Genome-wide Association (GWA) Data
    Release Date: June 1, 2011
     
  • NOT-HG-11-009 Notice of Amendment and Re-issuance of Administrative Supplements for the Addition of Standard Measures to Population-based Genomic Research: The PhenX Toolkit
    Release Date: January 21, 2011
     
  • RFA-HG-11-022 The Electronic Medical Records and Genomics (eMERGE) Network, Phase II - Pediatric Study Investigators (U01)
    Release Date: July 6, 2011

2010

  • PAR-11-032 Methods and Approaches for Detection of Gene-Environment Interactions in Human Disease (R21)
    Release Date: November 12, 2010
     
  • NOT-HG-11-001 Notice of Availability of Administrative Supplements for the Addition of Standard Measures to Population-Based Genomic Research: The PhenX Toolkit
    Release Date: October 8, 2010
     
  • RFA HG-10-009 The Electronic Medical Records and Genomics (eMERGE) Network, Phase II - Study Investigators (U01)
    Release Date: July 16, 2010
     
  • RFA HG-10-010 The Electronic Medical Records and Genomics (eMERGE) Network, Phase II - Coordinating Center (U01)
    Release Date: July 16, 2010

2009

  • NOT-HG-08-013 Notice of Publication of FAQs Related to RFA-HG-08-004: Genome-wide Association Studies of Treatment Response in Randomized Clinical Trials - Study Investigators (U01) 
    Release Date: September 12, 2008
     
  • NOT-HG-08-012 Correction for RFA-HG-08-005: Genome-wide Association Studies of Treatment Response in Randomized Clinical Trials - Coordinating Center (U01)
    Release Date: September 12, 2008
     
  • NOT-OD-07-088 Policy for Sharing of Data Obtained in NIH Supported or Conducted Genome-Wide Association Studies (GWAS)
    Release Date: August 28, 2007
     
    • Developed following a public consultation process with interested stakeholders, the GWAS data-sharing policy will facilitate the research community's access to genotype-phenotype datasets from GWAS in a broad array of disease areas.
       
    • GWAS Oversight Structure
      A chart of the governance of data-release policy for GWAS

 

  • NOT-OD-08-013 Implementation Guidance and Instructions for Applicants: Policy for Sharing of Data Obtained in NIH-Supported or Conducted Genome-Wide Association Studies (GWAS)
    Release Date: November 16, 2007
     
  • RFA-HG-09-014 Comparing Design Approaches for Sequencing Disease-Associated Regions Found in Genome-Wide Association Studies (U01)
    Letters of Intent Receipt Date(s): November 12, 2009; Application Receipt Date: December 11, 2009
     
  • RFA-HG-09-004 Follow-up Public Consultation to Inform the Design of a Possible Longitudinal Cohort Study of the Role of Genes and Environment in Health and Disease: Limited Competition (U01) 
    Letters of Intent Receipt Date(s): January 3, 2009; Application Receipt Date: February 3, 2009
     
  • RFA-MH-09-120 Informing Systems Biology through Genetic Variation: The Genes, Environment and Health Initiative (R21)
    Letters of Intent Receipt Date(s): December 14, 2008; Application Receipt Date: January 14, 2009

2008

  • NOT-CA-08-011 Administrative Supplements for Gene Identification Efforts: Replication and Fine-Mapping Studies for The Genes, Environment, and Health Initiative (GEI)
    Release Date: March 5, 2008
     
  • RFA-CA-09-003 Replication and Fine-Mapping Studies for the Genes, Environment, and Health Initiative (GEI) (R01)
    Letters of Intent Receipt Date(s): October 24, 2008; Application Receipt Date: December 1, 2008
     
  • RFA-DK-08-003 Implementation Planning Grants for Educational, Behavioral, or Social Studies for Translation of Genetic Factors in Common Diseases (U34)
    Letters of Intent Receipt Date(s): October 24, 2008; Application Receipt Date: November 25, 2008 
     
  • RFA-DK-08-004 Translation of Common Disease Genetics into Clinical Applications (R21) 
    Letters of Intent Receipt Date(s): October 24, 2008; Application Receipt Date: November 25, 2008
     
  • RFA-HG-08-004 Genome-wide Association Studies of Treatment Response in Randomized Clinical Trials - Study Investigators (U01) 
    Letters of Intent Receipt Date(s): October 13, 2008; Application Receipt Date: November 13, 2008
     
  • RFA-HG-08-005 Genome-wide Association Studies of Treatment Response in Randomized Clinical Trials - Coordinating Center (U01) 
    Letters of Intent Receipt Date(s): October 13, 2008; Application Receipt Date: November 13, 2008
     
  • RFA-DA-09-003 Functional Characterization of Genetic Variants and Interactions: The Genes, Environment and Health Initiative (R21)
    Letters of Intent Receipt Date(s): September 17, 2008; Application Due Date(s): October 17, 2008
     
  • RFA-DA-09-004 Functional Characterization of Genetic Variants and Interactions: The Genes, Environment and Health Initiative (R03) 
    Letters of Intent Receipt Date(s): September 17, 2008; Application Due Date(s): October 17, 2008
     

2007

  • RFA-HG-07-005 Genome-Wide Studies in Biorepositories with Electronic Medical Record Data (U01)
     
  • RFA-HG-07-006 High-Priority Phenotype and Exposure Measures for Cross-Study Analysis in Genome-Wide Association Studies (U01)
     
  • RFA-HG-07-012 Genome-wide Association Studies in the Genes, Environment, and Health Initiative - Study Investigators (U01) (re-issue of RFA-HG-06-033)
     
  • RFA-HG-07-014 Epidemiologic Investigation of Putative Causal Genetic Variants-Study Investigators (U01)
     
  • RFA-HG-07-015 Epidemiologic Investigation of Putative Causal Genetic Variants-Coordinating Center (U01)

    NOT-LM-07-001 Genotype and Phenotype Data Now Available from dbGaP Database; Request Process Involves New Procedures for Principal Investigators and Signing Officials
     
  • NOT-HG-08-001 Notice of Publication of FAQs Related to RFA-HG-07-014: Epidemiologic Investigation of Putative Causal Genetic Variants-Study Investigators (U01)
    Release Date: October 16, 2007
     
  • NOT-HG-07-026 Notice to Allow Resubmissions to RFA-HG-07-012: Genome-wide Association Studies in the Genes, Environment, and Health Initiative - Study Investigators (U01)
     
  • NOT-OD-07-066 Notice of Availability of the Data Access Request System for the Genetic Association Information Network (GAIN)

2006

Division Staff

Leadership

Teri Manolio, M.D., Ph.D.
Teri Manolio, M.D., Ph.D.
  • Director
  • Division of Genomic Medicine

Program Directors

Heather A. Colley, M.S.
Heather A. Colley, M.S.
  • Program Director
  • Division of Genomic Medicine
Jyoti Dayal, M.S.
Jyoti G. Dayal, M.S.
  • Program Director
  • Division of Genomic Medicine
Lucia Hindorff, Ph.D., M.P.H.
Lucia Hindorff, Ph.D., M.P.H.
  • Epidemiologist
  • Division of Genomic Medicine
Rongling Li
Rongling Li, M.D., Ph.D., M.P.H.
  • Epidemiologist and Program Director
  • Division of Genomic Medicine
Ebony B. Madden, Ph.D.
Ebony B. Madden, Ph.D.
  • Program Director
  • Division of Genomic Medicine
Erin M. Ramos, Ph.D., M.P.H.
Erin M. Ramos, Ph.D., M.P.H.
  • Program Director
  • Division of Genomic Medicine
Robb Rowley
Robb Rowley, M.D.
  • Program Director
  • Division of Genomic Medicine
Heidi J. Sofia, Ph.D.
Heidi J. Sofia, Ph.D.
  • Program Director
  • Division of Genomic Medicine
Jeffrey P. Struewing, M.D.
Jeff Struewing, M.D.
  • Program Director
  • Division of Genomic Medicine
Simona Volpi, Pharm.D., Ph.D.
Simona Volpi, Ph.D.
  • Program Director
  • Division of Genomic Medicine
Ken Wiley, Jr., Ph.D.
Ken Wiley Jr, Ph.D.
  • Program Director
  • Division of Genomic Medicine
Anastasia L. Wise, Ph.D.
Anastasia L. Wise, Ph.D.
  • Program Director
  • Division of Genomic Medicine

Consultant

Generic Profile Photo
John Mulvihill
  • Medical Genetics Consultant
  • Division of Genomic Medicine

Program Staff

Chang
Christine Q. Chang
  • Scientific Program Coordinator
  • Division of Genomic Medicine
Generic Profile Photo
Gabriel F. Batzli
  • Scientific Program Analyst
  • Division of Genomic Medicine
Sheethal Jose
Sheethal Jose
  • Scientific Program Analyst
  • Division of Genomic Medicine
Cecelia Tamburro
Cecelia P. Tamburro
  • Scientific Program Analyst
  • Division of Genomic Medicine
Joanna C. Chau
Joanna C. Chau
  • Scientific Program Analyst
  • Division of Genomic Medicine
Natalie Pino
Natalie Pino
  • Scientific Program Analyst
  • Division of Genome Sciences
Carmen Demetriou
Carmen M. Demetriou
  • Scientific Program Assistant
  • Division of Genomic Medicine
Robert Fullem
Robert L. Fullem
  • Program Analyst
  • Division of Genome Sciences
Catherine Sillari
Catherine Sillari
  • Program Analyst
  • Division of Genomic Medicine
Michelle Cohen
Michelle R. Cohen
  • Program Analyst
  • Division of Genome Sciences
Peggy Hall
Peggy Hall
  • Program Analyst
  • Division of Genomic Medicine
Sylvia Garvey
Sylvia Garvey, M.P.H., C.P.H.
  • Program Specialist
  • Division of Genomic Medicine

Last updated: February 20, 2018